United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded Jun 15, 2026 · Filed Jun 16, 2026

On Jun 15, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$549.17 for US$5.49M under a trading plan, leaving 18,876 shares. Filed Jun 16, 2026 (Form 4).

Sold
10,000 shares
Price
US$549.17 average (US$538.52 to US$553.76)
Value
US$5.49M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 15, 2026Common StockOption exercise10,000US$117.7628,876Direct
Jun 15, 2026Common StockSale121US$538.5228,755Direct
Jun 15, 2026Common StockSale74US$539.4628,681Direct
Jun 15, 2026Common StockSale45US$540.6428,636Direct
Jun 15, 2026Common StockSale240US$541.6128,396Direct
Jun 15, 2026Common StockSale560US$543.5027,836Direct
Jun 15, 2026Common StockSale855US$545.6326,981Direct
Jun 15, 2026Common StockSale504US$546.5426,477Direct
Jun 15, 2026Common StockSale465US$547.7726,012Direct
Jun 15, 2026Common StockSale1,616US$548.6424,396Direct
Jun 15, 2026Common StockSale800US$549.8723,596Direct
Jun 15, 2026Common StockSale2,200US$550.8921,396Direct
Jun 15, 2026Common StockSale1,144US$551.9120,252Direct
Jun 15, 2026Common StockSale778US$553.1019,474Direct
Jun 15, 2026Common StockSale598US$553.7618,876Direct

Source

View original at SEC

Related